Ginexin-F

**Ginexin-F** is a branded pharmaceutical product containing standardized dried **ginkgo biloba leaf extract** (e.g., 40 mg, 80 mg, 120 mg, or 240 mg per tablet), developed by **SK chemicals** as Korea's leading blood circulation improver since 1992. It exerts **three major blood circulation actions**—lowering blood viscosity, expanding blood vessels, and improving blood flow—to treat **peripheral arterial circulatory disorders** (e.g., intermittent claudication), **dizziness**, **tinnitus**, **memory loss**, **concentration difficulty**, and symptoms of organic brain dysfunction or mild cognitive impairment. The extract is standardized to **24% flavonoid glycosides** and **6% terpene lactones** (ginkgolic acids <5 ppm), akin to EGb 761, with evidence from clinical studies supporting cognitive benefits as an adjunct to donepezil in amyloid PET-positive Alzheimer's disease patients, including K-MMSE improvements and reductions in amyloid oligomer biomarkers.[1][5][11]

Brand names

Ginexin-F